Showing results (41-50 of 693) with videos related to

Sort By:
Pageof 70
American Journal of Hematology|February 17, 2015
High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcomePreetesh Jain, Michael Keating, Phillip A Thompson, et al.
British Journal of Haematology|April 7, 2017
Characteristics, management, and outcomes of patients with follicular dendritic cell sarcomaPreetesh Jain, Sarah A Milgrom, Keyur P Patel, et al.
Leukemia & Lymphoma|February 22, 2018
Ibrutinib inhibits free fatty acid metabolism in chronic lymphocytic leukemiaUri Rozovski, David M Harris, Ping Li, et al.
Immunologic Research|October 20, 2015
Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesBarbara Sherry, Preetesh Jain, Pui Yan Chiu, et al.
Oncotarget|September 29, 2018
STAT3 is constitutively acetylated on lysine 685 residues in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal DysfunctionKoji Sasaki, Amit Lahoti, Elias Jabbour, et al.
Oncotarget|May 17, 2018
STAT3-activated CD36 facilitates fatty acid uptake in chronic lymphocytic leukemia cellsUri Rozovski, David M Harris, Ping Li, et al.
Molecular Cancer|September 26, 2022
TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphomaVivian Changying Jiang, Dapeng Hao, Preetesh Jain, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2016
Outcome of Patients With Therapy-Related Acute Myeloid Leukemia With or Without a History of MyelodysplasiaKoji Sasaki, Elias Jabbour, Jorge Cortes, et al.
The Lancet. Haematology|October 6, 2015
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 studyPreetesh Jain, Hagop Kantarjian, Elias Jabbour, et al.
Pageof 70